Astec Lifescienc

{
  "main_header": {
    "sid": 574204,
    "name": "Astec Lifescienc",
    "stock_name": "Astec Lifescienc",
    "full_name": "Astec Lifesciences Ltd",
    "name_url": "stocks-analysis/astec-lifescienc",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "755.35",
    "chg": -16.45,
    "chgp": "-2.13%",
    "dir": -1,
    "prev_price": "771.80",
    "mcapval": "1,705.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 533138,
    "symbol": "ASTEC",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 18,
    "indexname": "India SENSEX",
    "isin": "INE563J01010",
    "curr_date": "May 25",
    "curr_time": "",
    "bse_nse_vol": "21.65 k",
    "exc_status": "Active",
    "traded_date": "May 25, 2026",
    "traded_date_str": "2026 05 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astec-lifescienc-574204-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "HT",
      "url": "https://www.marketsmojo.com/mojopro/strategy/1",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astec-lifescienc-574204-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Astec Lifesciences Gains 14.15%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-gains-1415-4-key-factors-driving-the-weeks-momentum-4008701",
        "imagepath": "",
        "date": "2026-05-23 17:02:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Intraday high surge with 7.96% gain</p>\n                    <p><strong>19 May:</strong> Technical momentum shift amid mixed signals</p>\n                    <p><strong>20 May:</strong> Mojo Score upgraded to Sell from Strong Sell</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.772.65, +14.15% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.676.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.772.65</div><div class=\"stat-change po..."
      },
      {
        "title": "Astec Lifesciences Ltd Upgraded to Sell on Technical Improvements Despite Lingering Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astec-lifesciences-ltd-upgraded-to-sell-on-technical-improvements-despite-lingering-fundamental-concerns-4000317",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstecLifescienc_mojoScore_4000317.png",
        "date": "2026-05-20 08:08:11",
        "description": "Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 19 May 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental weaknesses, prompting investors to reassess its near-term prospects."
      },
      {
        "title": "Astec Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4000129",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstecLifescienc_technicaldot_4000129.png",
        "date": "2026-05-20 08:02:26",
        "description": "Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent day decline of 1.59%, the stock’s weekly and monthly technical indicators reveal a complex interplay of bullish and bearish signals, warranting a nuanced analysis for investors navigating this evolving landscape."
      },
      {
        "title": "Astec Lifesciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3997972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstecLifescienc_technicaldot_3997972.png",
        "date": "2026-05-19 08:03:23",
        "description": "Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. The stock surged 10.90% on 19 May 2026, closing at ₹750.65, marking a significant rebound from its previous close of ₹676.90. This movement comes amid a broader sideways technical trend, with key indicators such as MACD and Bollinger Bands signalling mixed sentiments across weekly and monthly timeframes."
      },
      {
        "title": "Astec Lifesciences Ltd Surges 7.96% to Day's High of Rs 734.4 — Outperforms Sector by 10.36 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astec-lifesciences-ltd-hits-intraday-high-with-796-surge-on-18-may-2026-3996959",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstecLifescienc_priceRelatedfactors_3996959.png",
        "date": "2026-05-18 11:15:48",
        "description": "The Sensex declined 0.73% on 18 May 2026, while Astec Lifesciences Ltd surged 7.96%, marking a striking 10.36-percentage-point outperformance over its sector. This sharp intraday gain, reaching a high of Rs 734.4, stands out as a stock-specific event amid broader market weakness."
      },
      {
        "title": "Astec Lifesciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astec-lifesciences-ltd-is-rated-strong-sell-3991041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstecLifescienc_mojoScore_3991041.png",
        "date": "2026-05-14 10:11:00",
        "description": "Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 Sep 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Astec Lifesciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astec-lifesciences-ltd-is-rated-strong-sell-3972942",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstecLifescienc_mojoScore_3972942.png",
        "date": "2026-05-03 10:10:13",
        "description": "Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 Sep 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 03 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Astec Lifesciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-astec-lifesciences-ltd-latest-results-good-or-bad-3967121",
        "imagepath": "",
        "date": "2026-04-28 19:13:57",
        "description": "Astec Lifesciences Ltd's latest financial results for the quarter ending March 2026 reflect a complex operational landscape. The company reported net sales of ₹158.62 crores, marking a year-on-year growth of 32.70% compared to ₹119.53 crores in the same quarter last year. This growth is notable as it represents the highest quarterly revenue in recent periods, indicating a return of revenue growth momentum.\n\nDespite the positive sales figures, Astec experienced a net loss of ₹7.76 crores in Q4 FY26, which, while an improvement from previous quarters, underscores ongoing challenges in achieving profitability. The company's operating profit before depreciation, interest, tax, and other income (PBDIT) turned positive at ₹9.16 crores, a significant increase from ₹3.99 crores in Q3 FY26, with an operating margin of 5.77%, up from 3.20% in the prior quarter. However, these margins remain considerably lower than hi..."
      },
      {
        "title": "Astec LifeSciences Q4 FY26: Losses Narrow but Fundamental Challenges Persist",
        "link": "https://www.marketsmojo.com/news/result-analysis/astec-lifesciences-q4-fy26-losses-narrow-but-fundamental-challenges-persist-3966773",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstecLifescienc_quaterlyResult_3966773.png",
        "date": "2026-04-28 12:48:34",
        "description": "Astec LifeSciences Ltd., a Godrej group company specialising in agrochemical active ingredients and pharmaceutical intermediates, reported a consolidated net loss of ₹7.76 crores for Q4 FY26, marking a significant improvement from the ₹15.70 crores loss in the previous quarter. Despite the sequential improvement, the company remains in loss-making territory for the fifth consecutive quarter, with the stock trading at ₹726.40 as of April 28, 2026, down 3.02% on the day and commanding a market capitalisation of ₹1,618.58 crores."
      }
    ],
    "total": 258,
    "sid": "574204",
    "stock_news_url": "https://www.marketsmojo.com/news/astec-lifesciences-574204"
  },
  "announcements": [
    {
      "details": "Astec LifeSciences Limited has informed the Exchange that Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has submitted a copy of disclosure on Related Party Transactions for the Half Year ended September 30, 2019 on a consolidated basis, drawn in accordance with the applicable Accounting Standards.",
      "source": "NSE",
      "caption": "Astec LifeSciences Limited - Other General Purpose",
      "datetime": "22-Nov-2019"
    },
    {
      "details": " <table><tr><td>Astec LifeSciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 26, 2019. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. </td></tr></table>",
      "source": "NSE",
      "caption": "Shareholders meeting",
      "datetime": "27-Jul-2019"
    },
    {
      "details": " <table><tr><td>Astec LifeSciences Limited has informed the Exchange regarding Outcome of Board Meeting held on July 26, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Outcome of Board Meeting",
      "datetime": "26-Jul-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astec Lifesciences Ltd has declared <strong>15%</strong> dividend, ex-date: 21 Jul 23",
          "dt": "2023-07-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Astec Lifesciences Ltd has announced <strong>1:7</strong> rights issue, ex-date: 04 Jul 25",
          "dt": "2025-07-04",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Astec Lifesciences Gains 14.15%: 4 Key Factors Driving the Week’s Momentum

2026-05-23 17:02:07

Key Events This Week

18 May: Intraday high surge with 7.96% gain

19 May: Technical momentum shift amid mixed signals

20 May: Mojo Score upgraded to Sell from Strong Sell

22 May: Week closes at Rs.772.65, +14.15% for the week

Week Open

Rs.676.90

Week Close

Rs.772.65

Read full news article

Astec Lifesciences Ltd Upgraded to Sell on Technical Improvements Despite Lingering Fundamental Concerns

2026-05-20 08:08:11

Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 19 May 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental weaknesses, prompting investors to reassess its near-term prospects.

Read full news article

Astec Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-20 08:02:26

Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent day decline of 1.59%, the stock’s weekly and monthly technical indicators reveal a complex interplay of bullish and bearish signals, warranting a nuanced analysis for investors navigating this evolving landscape.

Read full news article

Astec Lifesciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-05-19 08:03:23

Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. The stock surged 10.90% on 19 May 2026, closing at ₹750.65, marking a significant rebound from its previous close of ₹676.90. This movement comes amid a broader sideways technical trend, with key indicators such as MACD and Bollinger Bands signalling mixed sentiments across weekly and monthly timeframes.

Read full news article

Astec Lifesciences Ltd Surges 7.96% to Day's High of Rs 734.4 — Outperforms Sector by 10.36 Percentage Points

2026-05-18 11:15:48

The Sensex declined 0.73% on 18 May 2026, while Astec Lifesciences Ltd surged 7.96%, marking a striking 10.36-percentage-point outperformance over its sector. This sharp intraday gain, reaching a high of Rs 734.4, stands out as a stock-specific event amid broader market weakness.

Read full news article

Astec Lifesciences Ltd is Rated Strong Sell

2026-05-14 10:11:00

Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 Sep 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Astec Lifesciences Ltd is Rated Strong Sell

2026-05-03 10:10:13

Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 Sep 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 03 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Astec Lifesciences Ltd latest results good or bad?

2026-04-28 19:13:57

Astec Lifesciences Ltd's latest financial results for the quarter ending March 2026 reflect a complex operational landscape. The company reported net sales of ₹158.62 crores, marking a year-on-year growth of 32.70% compared to ₹119.53 crores in the same quarter last year. This growth is notable as it represents the highest quarterly revenue in recent periods, indicating a return of revenue growth momentum. Despite the positive sales figures, Astec experienced a net loss of ₹7.76 crores in Q4 FY26, which, while an improvement from previous quarters, underscores ongoing challenges in achieving profitability. The company's operating profit before depreciation, interest, tax, and other income (PBDIT) turned positive at ₹9.16 crores, a significant increase from ₹3.99 crores in Q3 FY26, with an operating margin of 5.77%, up from 3.20% in the prior quarter. However, these margins remain considerably lower than hi...

Read full news article

Astec LifeSciences Q4 FY26: Losses Narrow but Fundamental Challenges Persist

2026-04-28 12:48:34

Astec LifeSciences Ltd., a Godrej group company specialising in agrochemical active ingredients and pharmaceutical intermediates, reported a consolidated net loss of ₹7.76 crores for Q4 FY26, marking a significant improvement from the ₹15.70 crores loss in the previous quarter. Despite the sequential improvement, the company remains in loss-making territory for the fifth consecutive quarter, with the stock trading at ₹726.40 as of April 28, 2026, down 3.02% on the day and commanding a market capitalisation of ₹1,618.58 crores.

Read full news article

View All News